Dr / BSC, PhD, MBA /CBE, Dr Hc FRSE
Cell Therapy Catapult, Synpromics Ltd, Roslin Foundation Non-Exec: Quantum Pharma
Pro Vice Chancellor for the Faculty of Science and Director of the UK Regenerative Medicine Platform Hub
MA (Cantab) Hons; FCA, barrister-at -law, CUH NHS Foundation Trust, consultant adviser to private equity
Stefan Ogrodzinski received his BSc (Hons) in Toxicology and Pharmacology from The School of Pharmacy, University of London, in 1987 and his MBA from De Montfort University in 1999.
Senior Pro Vice-Chancellor (Research) at Nottingham Trent University
BSc (Hons) First Class in Biomedical Sciences, University of Ulster – 1986
Glenn has a first degree in Genetics and a D Phil in Immunology. He qualified as a chartered accountant with Ernst & Young and worked in the life science practice for a number of years.
Paul was appointed as BioCity’s Chief Financial Officer in November 2015, having previously been Chief Financial Officer of the pharmaceutical company, Vectura Group plc.
Toby is responsible for running the site services, business development and accelerator programmes at BioCity and MediCity. His career started in engineering and project management.
BioHub Alderley Park
BioCity Expert Network
BioHub Alderley Park Ventures